Research & Projects

ESCMID Panorama

ESCMID Study Group for Bloodstream Infections and Sepsis - ESGBIS

News & Activities

ESGBIS and ESGAP (antibiotic policies group) aim to explore current practices regarding management of bacteraemia/candidaemia, in order to get an international picture on the topic.

The survey is intended for (senior or trainee) specialists in infectious diseases or clinical microbiology, or clinical pharmacists, or any healthcare professional part of an antimicrobial stewardship team worldwide, provided that these professionals regularly give advice on antibiotic treatment of patients with positive blood cultures in their hospital (outside their own department).

The questionnaire will take around 5 to 7 minutes. It is strictly anonymous. If you want to participate, you can find the questionnaire here.

Do not hesitate to motivate colleagues who might be interested in participating. The survey will stay open until the end of February 2017.

We would like to encourage access and use of national data from ESGAP/ESGBIS studies, to support national and regional activities within antimicrobial stewardship. Specifically, registered ESGAP/ESGBIS members can request the raw national data for this bloodstream infection survey, if a significant number of responses have been reached in their country, as defined below:

  • Countries with population >25 million = 50 responses (e.g. France, Germany, Italy, Poland, Spain, Turkey, United Kingdom)
  • Countries with population <25 million = 20 responses (e.g. all other European countries)

The data may be used in many ways, including:

  • Presentations at regional, national and international conferences
  • Publications in national and international journals
  • Supporting national and regional improvements in education, research and practice

We thank you very much for your help.

- Prof. Céline Pulcini (ESGAP secretary) and Prof. Winfried Kern (ESGBIS chair)
on behalf of the ESGAP/ESGBIS bloodstream infection scientific committee (Guillaume Béraud, Kevin Diallo, Önder Ergonul, Maddalena Giannella, Winfried Kern, Diamantis Kofteridis, Tomislav Kostyanev, Céline Pulcini, José Ramón Paño-Pardo, Pilar Retamar, and Nathalie Thilly)

Here is the new ESGBIS Executive Committee:

  • Winfried V. Kern, Germany (Chairperson)
  • Pilar Retamar Gentil, Spain (Secretary)
  • W. Joost Wiersinga, Netherlands (Treasurer)
  • Yehuda Carmeli, Israel (Elected Board Member)
  • Maddalena Giannella, Italy (Elected Board Member)
  • Bruno Hoen, Guadeloupe (Ad-hoc Board Member, Endocarditis)

We welcome Maddalena and are looking forward to continuing this work in the new positions. Bruno Hoen from France/Guadeloupe was recently appointed ad-hoc member and will bring in ideas for research in the area of endocarditis and other cardiovascular infections.

  • Saturday, 9 April 2016
    11.00 h - 13.00 h (Hall E)
    2-hour Educational Workshop EW015: Contemporary trial methods in clinical effectiveness research
  • Sunday, 10 April 2016
    11.30 h - 12.30 h (Hall E)
    1-hour Symposium SY053: Prevention and management of bloodstream infections: from here to where?
    13.15 h - 14.15 h (Room: E104/105)
    ESGBIS Meeting: All interested persons are cordially invited to join the meeting and plan future Study Group activities.
  • Tuesday, 12 April 2016
    9.00 h - 11.00 h (Hall K)
    2-hour Symposium SY133: Splenic function and infection
    13.30 h - 15.30 h (Hall E)
    2-hour Symposium SY147: Understanding host-bacterial interactions - getting by with a little help from our friends
  • Saturday, 25 April 2015
    08.45 - 10.45 (Hall B)
    ESGBIS Educational Workshop EW02: Management of severe sepsis and septic shock anno 2015. Organized jointly with the International Sepsis Forum (ISF) 
  • Sunday, 26 April 2015
    13.15 - 14.15 (Hall M)
    ESGBIS Business Meeting: All interested persons are cordially invited to join the meeting and plan future Study Group activities.
  • Monday, 27 April 2015
    14.30 - 15.30 (Hall D)
    ESGBIS Symposium SY38: Bloodstream infections and sepsis in the elderly: challenges and prospects. Organized jointly with the Elderly Infections Group (ESGIE).
  • Tuesday, 28 April 2015
    13.30 - 15.30 (Hall H)
    ESGBIS Sympsium SY58: Bloodstream infections in the era of MDR and XDR Gram-negative bacteria. Organized jointly with the Antimicrobial Resistance Surveillance Group (ESGARS).

International Staphylococcus aureus Collaboration (ISAC)

The International Staphylococcus aureus Collaboration (ISAC) has joined forces with ESGBIS to study S. aureus bloodstream infection. The international consortium currently conducts a large, multinational, observational study on S. aureus bloodstream infection.

ISAC has formed to conduct observational and controlled trials with a focus on S. aureus infection. Furthermore, the group wants to provide a framework for training future clinical scientists and increase opportunities for biomedical and outcomes research into Staphylococcus aureus infection.


  • Saturday, 10 May 2014
    11.00 - 13.00 (Hall C)
    Educational Workshop 12: Bloodstream infections: opportunities for outcome improvement.
  • Sunday, 11 May 2014
    7.45 - 8.45 (Hall A)
    ESGBIS Meet-the-Expert Session: Sepsis management beyond antibiotics.
  • Monday, 12 May 2014
    09.00 - 11.00 (Hall J)
    ESGBIS Symposium: Staphylococcus aureus bacteraemia: controversial issues.
    13.15 - 14.15 (Room 125)
    ESGBIS Business Meeting: All interested persons are cordially invited to join the meeting and plan future Study Group activities.

In mBio, scientists from bioMérieux, Inc. describe a new method that could cut hours off the time it takes to diagnose blood infections while also eliminating the need for complicated manual processing and expensive equipment.

The lysis centrifugation-intrinsic fluorescence (LC-IF) method combines lysis of blood cells, centrifugation of bacteria or fungi in the sample, and fluorescence measurement to analyse the particular fingerprint of any pathogens present in the sample. The scientists report the method to correctly identify the species of bacteria or fungi in 96.5 % of positive blood culture samples.

New ESCMID Study Group

ESGBIS is a newly formed ESCMID Study Group, which has started its activities in the field of bloodstream infections and sepsis. The constitutional meeting will be held at ECCMID 2013 in Berlin, DE, Sunday, 28 April, 15.30 - 16.30 (Salon 13/14).

Objectives of ESGBIS


Last update: 01 December 2016

Download the latest Annual Report.